Search Within

Mark Kris

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (115)
  2. Meeting Abstract (107)
  3. Research Letter (1)
Groups
  1. Department of Medicine (223)
  2. GSK Faculty (223)
  3. Human Oncology and Pathogenesis Program (223)
  4. Solid Tumor Oncology Division (223)
  5. Thoracic Oncology (223)
  6. Department of Pathology and Laboratory Medicine (209)

More Groups

People
  1. Marc Ladanyi (189)
  2. Gregory Riely (128)
  3. Maria Arcila (96)
  4. Charles Rudin (63)
  5. Maureen Zakowski (63)
  6. Helena Yu (61)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (11)
  4. 2022 (10)
  5. 2021 (8)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Journal of Thoracic Oncology (38)
  3. Clinical Cancer Research (35)
  4. Cancer Discovery (7)
  5. Modern Pathology (7)
  6. Laboratory Investigation (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (72)
  2. American Association for Cancer Research (47)
  3. Elsevier Inc. (44)
  4. Nature Publishing Group (10)
  5. Oxford University Press (10)
  6. Nature Research (7)

More Publishers

Results (223)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
    Journal Article

    Inoue-Yamauchi, A.; Jeng, P. S.; Kim, K.; Chen, H. C.; Han, S.; Ganesan, Y. T.; Ishizawa, K.; Jebiwott, S.; Dong, Y.; Pietanza, M. C.; more...
    Nature Communications (2017)

    Fulltext@MSK | Save
  • Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies
    Journal Article

    Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Histologic patterns of lung cancers associated with MET exon 14 splice site alterations (MESSA): A study of 58 Cases
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Lai, V.; Kris, M.; Drilon, A.; Arcila, M. E.; Ladanyi, M.; Rekhtman, N.; Travis, W.
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • Histologic patterns of lung cancers associated with MET exon 14 splice site alterations (MESSA): A study of 58 cases
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Lai, V.; Kris, M.; Drilon, A.; Arcila, M. E.; Ladanyi, M.; Rekhtman, N.; Travis, W.
    Laboratory Investigation (2017)

    Fulltext@MSK | Save
  • Concurrent genetic alterations identified by next-generation sequencing in pre-treatment metastatic EGFR-mutant lung cancers
    Meeting Abstract

    Yu, H. A.; Jordan, E.; Ni, A.; Feldman, D.; Rodriguez, C.; Kim, H. R.; Kris, M. G.; Solit, D. B.; Berger, M. F.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers
    Meeting Abstract

    Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Association of outcomes and co-occuring genomic alterations in patients with KRAS-mutant non-small cell lung cancer
    Meeting Abstract

    Riely, G.; Jordan, E.; Kim, H. R.; Yu, H. A.; Berger, M. F.; Solit, D. B.; Kris, M. G.; Ni, A.; Arcila, M. E.; Ladanyi, M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identifying HER2 mutation, amplification, and HER2 protein overexpression as therapeutic targets in lung cancers
    Meeting Abstract

    Li, B. T.; Zheng, T.; Ni, A.; Hellmann, M. D.; Jordan, E.; Barron, D.; Smyth, L. M.; Solit, D. B.; Zehir, A.; Ross, D. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection
    Meeting Abstract

    Jordan, E.; Barron, D.; Schultz, N.; Chakravarty, D.; Kris, M. G.; Rudin, C. M.; Li, B. T.; Yu, H. A.; Drilon, A. E.; Rusch, V. W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
    Journal Article

    Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save